Literature DB >> 28279758

Assessment of the potential for oritavancin MIC changes among Staphylococcus aureus nasal carriage isolates following systemic oritavancin treatment in a phase 2 study in patients with acute bacterial skin and skin-structure infections.

Francis F Arhin1, Gregory Moeck2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28279758     DOI： 10.1016/j.jgar.2017.01.003

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN： 2213-7165            Impact factor:   4.035


× No keyword cloud information.
  3 in total

1.  Oritavancin (Orbactiv): A New-Generation Lipoglycopeptide for the Treatment Of Acute Bacterial Skin and Skin Structure Infections.

Authors:  Samantha Rosenthal; Arnold G Decano; Aiman Bandali; Denise Lai; Gregory E Malat; Tiffany E Bias
Journal:  P T       Date:  2018-03

Review 2.  New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides.

Authors:  Truc T Tran; Sara Gomez Villegas; Samuel L Aitken; Susan M Butler-Wu; Alex Soriano; Brian J Werth; Jose M Munita
Journal:  Antimicrob Agents Chemother       Date:  2022-04-27       Impact factor: 5.938

3.  Effectiveness and safety of Liuhedan for treating cellulitis: A protocol for systematic review and meta-analysis.

Authors:  Na Li; Li Zhang; Pan Pan; Tao Cheng; Shu-Yun Xu
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.